REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Cancer-Associated Thrombosis (CAT)
In brief
This study is researching an experimental drug called REGN7508 (called "study drug"). The study is focused on the prevention of Cancer-Associated Thrombosis (CAT) in participants. The aim of the study is to see how effective the study drug is in preventing blood clots in participants with solid tumors who are currently receiving anticancer treatment or planning to start anticancer treatment within a month of being assigned to a study treatment, or recovering from surgery, and how the study drug compares to placebo for CAT. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects)
Key facts
- Study ID
- NCT07410117
- Run by
- Regeneron Pharmaceuticals
- People needed
- 1120
- Starts
- 2026-03-09
- Expected to finish
- 2030-05-06
- Last updated by the study team
- 2026-07-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Bioresearch Partner- Hialeah Hospital — Hialeah, Florida, United States (enrolling)
- Helios Clinical Research — North Miami Beach, Florida, United States (enrolling)
- El Paso Medical Research Institute (Medresearch Inc) — El Paso, Texas, United States (enrolling)
- LTD High Technology Hospital Medcenter — Batumi, Adjara, Georgia (enrolling)
- Krystyna Kiel Oncology Center — Kutaisi, Imereti, Georgia (enrolling)
- American Hospital Tbilisi — Tbilisi, Georgia (enrolling)
- Llc Todua Clinic — Tbilisi, Georgia (enrolling)
- Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic — Tbilisi, Georgia (enrolling)
- Institute of Clinical Oncology — Tbilisi, Georgia (enrolling)
- JSC Evex Hospitals - Caraps Medline — Tbilisi, Georgia (enrolling)
- LTD Cancer Research Centre — Tbilisi, Georgia (enrolling)
- Caucasus Medical Centre — Tbilisi, Georgia (enrolling)
- Yamaguchi University Hospital — Ube, Yamaguchi, Japan (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.